Fifth Third Bancorp Alkermes Plc. Transaction History
Fifth Third Bancorp
- $27.3 Billion
- Q3 2024
A detailed history of Fifth Third Bancorp transactions in Alkermes Plc. stock. As of the latest transaction made, Fifth Third Bancorp holds 879 shares of ALKS stock, worth $25,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
879
Previous 658
33.59%
Holding current value
$25,904
Previous $15,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALKS
# of Institutions
361Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$858 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$559 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$383 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$373 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$271 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.84B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...